Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging

International Journal of Cardiology

Volumn 199, Issue , 2015, Pages 326-332

  Roghi, Alberto ^a   Poggiali, Erika ^b,c   Duca, Lorena ^c   Mafrici, Antonio ^d   Pedrotti, Patrizia ^a   Paccagnini, Stefania ^a   Brenna, Sergio ^a   Galli, Alessio ^c   Consonni, Dario ^c   Cappellini, Maria Domenica ^b,c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Iron; Myocardial infarction; Non Transferrin Bound Iron; Reperfusion injury

Indexed keywords

CREATINE KINASE MB; INTERLEUKIN 6; IRON; MALONALDEHYDE; NON TRANSFERRIN BOUND IRON; TROPONIN T; UNCLASSIFIED DRUG; IL6 PROTEIN, HUMAN; TRANSFERRIN;

ADULT; ARTICLE; BLEEDING; CARDIAC IMAGING; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE INJURY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; MICROANGIOPATHY; MOLECULAR PATHOLOGY; MYOCARDIAL DISEASE; MYOCARDIAL HEMORRHAGE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; CARDIAC MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; MICROCIRCULATION; MICROVASCULATURE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; REPERFUSION INJURY;

CREATINE KINASE, MB FORM; FEMALE; HEMORRHAGE; HUMANS; INTERLEUKIN-6; IRON; MAGNETIC RESONANCE IMAGING; MALE; MALONDIALDEHYDE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REPERFUSION INJURY; TRANSFERRINS; TROPONIN T; VENTRICULAR REMODELING;

EID: 84941588296     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.056     Document Type: Article

References (42)

1. R.A. Kloner, G.E. Ganote, and R.B. Jennings The "no-reflow" phenomenon after temporary occlusion in the dog J. Clin. Invest. 54 1974 1496 1508
2. B.L. Gerber, C.E. Rochitte, J.A. Merlin, E.R. McVeigh, D.A. Bluemke, K.C. Wu, L.C. Becker, and J.A.C. Lima Microvascular obstruction and left ventricular remodelling early after acute myocardial infarction Circulation 101 2000 2734 2741
3. K.C. Wu, E.A. Zerhouni, R.M. Judd, C.H. Lugo-Olivieri, L.A. Barouch, S.P. Schulman, R.S. Blumenthal, and J.A.C. Lima The prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
4. A. Kidambi, A.N. Mather, M. Motwani, P. Swoboda, A. Uddin, J.P. Greenwood, and S. Plein The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insight from cardiovascular magnetic resonance J. Cardiovasc. Magn. Reson. 15 2013 58 67
5. E. Dall'Armellina, N. Karia, A.C. Lindsay, T.D. Karamitsos, V. Ferreira, M.D. Robson, P. Kellman, J.M. Francis, C. Forfar, B.D. Prendergast, A.P. Banning, K.M. Channon, R.K. Kharbanda, S. Neubauer, and R.P. Choundry Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index Circ. Cardiovasc. Imaging 4 2011 228 236
6. R. Andrè, V. Bongard, R. Elosua, I. Kirchberger, D. Farmakis, U. Häkkinen, D. Fusco, M. Torre, P. Garel, C. Araújo, C. Meisinger, J. Lekakis, A. Malmivaara, M. Dovali, M. Pereira, J. Marrugat, and J. Ferrière International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study Heart 100 2014 1201 1207
7. C.E. Rochitte, R.J. Kim, H.B. Hillebrand, E. Chen, and J.A.C. Lima Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction Circ. Res. 87 2000 648 655
8. J.A.C. Lima, R.M. Judd, A. Bazille, S.P. Schulman, E. Atalar, and E.A. Zerhouni Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms Circulation 92 1995 1117 1125
9. W. Chan, A.J. Taylor, A.H. Ellims, L. Lefkovitis, C. Wong, B.A. Kingwell, A. Natoli, K.D. Croft, T. Mori, D.M. Kaye, A.M. Dart, and S.J. Duffy Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction Circ. Cardiovasc. Interv. 5 2012 270 278
10. N.R. Ghugre, J. Barry, J.C. Wood, A. Moody, B.H. Strauss, and G. Wright Role of iron chelation in hemorrhagic myocardial infarction: a quantitative CMR study 15th Annual SCMR Scientific Session, Abstract J. Cardiovasc. Magn. Reson. 14 Suppl.1 2012 P20
11. B.J. Van Lenten, J. Prieve, M. Navab, S. Hama, A.J. Lusis, and A.M. Fogelman Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo J. Clin. Invest. 95 1995 2104 2110
12. G. Ambrosio, J.L. Zweier, W.E. Jacobus, M.L. Weisfeldt, and J.T. Flaherty Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury Circulation 76 1987 906 915
13. A.M. van der Kraaij, L.J. Mostert, H.G. van Eijk, and J.F. Koster Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine Circulation 78 1988 442 449
14. J.W. Eaton, and M. Qian Molecular bases of cellular iron toxicity Free Radic. Biol. Med. 32 2002 833 840
15. X. Gao, M. Qianb, J.L. Campian, J. Marshall, Z. Zhoud, A.M. Roberts, J. Kang, S.D. Prabhuc, X.F. Suna, and J.W. Eaton Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload Free Radic. Biol. Med. 49 2010 401 407
16. 2 + channels in iron transport and iron overload cardiomyopathy J. Mol. Med. 84 2006 349 364
17. O. Loreal, I. Gosriwatana, D. Guyader, J. Porter, P. Brissot, and R.C. Hider Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method J. Hepatol. 32 2000 121 733
18. A. Piga, F. Longo, L. Duca, S. Roggero, T. Vinciguerra, R. Calabrese, C. Hershko, and M.D. Cappellini High nontransferrin bound iron levels and heart disease in thalassemia major Am. J. Hematol. 84 2009 29 33
19. M. Sulieman, R. Asleh, Z.I. Cabantchik, W. Breuer, D. Aronson, A. Suleiman, R. Miller-Lotan, H. Hammerman, and A.P. Levy Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes Diabetes Care 27 2004 2730 2732
20. A. Cortelezzi, C. Cattaneo, S. Cristiani, L. Duca, B. Sarina, G.L. Delilers, G. Fiorelli, and M.D. Cappellini Non-transferrin-bound iron in myelodysplastic syndrome: a marker of ineffective erythropoiesis ? Hematol. J. 1 2000 153 158
21. M.P. Kooistra, S. Kersting, I. Gosriwatana, S. Lu, J. Nijhoff-Schutte, R.C. Hider, and J.J.M. Marx Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion Eur. J. Clin. Invest. 32 2002 36 41
22. J. Wood, T. Glynos, A. Thompson, P. Giardina, P. Harmatz, B.P. Kang, C. Paley, and T.D. Coates Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial Haematologica 96 2011 1055 1058
23. J. Wood Impact of iron assessment by MRI Hematology 1 2011 443 450
24. S. Giri, Y.C. Chung, A. Merchant, G. Mihai, S. Rajagopalan, S.V. Raman, and O.P. Simonetti T2 quantification for improved detection of myocardial edema J. Cardiovasc. Magn. Reson. 11 2009 56
25. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council of Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
26. R.Y. Kwong, and A. Farzaneh-Far Measuring myocardial scar by CMR J. Am. Coll. Cardiol. Cardiovasc. Img. 4 2011 157 159
27. E. Wu, R.M. Judd, and J.D. Vargas Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q wave myocardial infarction Lancet 357 2001 21 28
28. I. Gosriwatana, O. Loreal, S. Lu, P. Brissot, J. Porter, and R.C. Hider Quantification of non-transferrin-bound iron in the presence of unsaturated transferring Anal. Biochem. 273 1999 212 220
29. B. Modell, M. Khan, M. Darlison, M.A. Westwood, D. Ingram, and D.J. Pennell Improved survival of thalassemia major in the UK and relation to T2∗cardiovascular magnetic resonance J. Cardiovasc. Magn. Reson. 10 2008 42 50
30. C. Borgna-Pignatti, S. Rugolotto, P. De Stefano, H. Zhao, M.D. Cappellini, G.C. Del Vecchio, M.A. Romeo, G.L. Forni, M.R. Gamberini, R. Ghilardi, A. Piga, and A. Cnaan Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine Haematologica 89 2004 1187 1193
31. E.M.G. Jacobs, J.C.M. Hendriks, B.L.J.H. van Tits, P.J. Evans, W. Breuer, D.Y. Liu, E.H.J.M. Jansen, K. Jauhiainen, B. Sturm, J.B. Porter, B. Scheiber-Mojdehkar, L. von Bonsdorff, Z.I. Cabantchik, R.C. Hider, and D.W. Swinkels Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform Anal. Biochem. 341 2005 241 250
32. L.J. Anderson, S. Holden, B. Davis, E. Prescott, C.C. Charrier, N.H. Bunce, D.N. Firmin, B. Wonke, J. Porter, J.M. Walker, and D.J. Pennell Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload Eur. Heart J. 22 2001 2171 2179
33. J.B. Porter, R.D. Abeysinghe, L. Marshall, R.C. Hider, and S. Singh Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy Blood 88 1996 705 713
34. D.L. Steen, C.P. Cannon, S.S. Lele, M.M. Rajapurkar, B. Mukhopadhay, B. Scirica, S. Murphy, and D.A. Morrow Prognostic evaluation of catalytic iron in patients with acute coronary syndromes Clin. Cardiol. 36 2013 139 145
35. C. Basso, and G. Thiene The pathophysiology of myocardial reperfusion: a pathologist's perspective Heart 92 2006 1559 1562
36. M. Zia, N.R. Ghugre, K.A. Connelly, B.H. Strauss, J.D. Sparkes, A.J. Dick, and G.A. Wright Characterizing myocardial edema and hemorrhage using quantitative T2 and T2∗mapping at multiple time intervals post ST-segment elevation myocardial infarction Circ. Cardiovasc. Imaging 5 2012 566 572
37. I. Eitel, K. Kubusch, O. Strohm, S. Desch, Y. Mikami, S. de Waha, M. Gutberlet, G. Schuler, M. Friedrich, and H. Thiele Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction Circ. Cardiovasc. Imaging 4 2011 354 362
38. A.N. Mather, T.A. Fairbairn, S.G. Ball, J.P. Greenwood, and S. Plein Reperfusion hemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk Heart 97 2011 453 459
39. A. Kali, A. Kumar, I. Cokic, R.L.Q. Tang, S.A. Tsaftaris, M.G. Friederich, and R. Dharmakumar Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition. A cardiovascular magnetic resonance study with ex vivo validation Circ Cardiovasc Imaging 6 2013 218 228
40. I. Guillen, M. Blanes, M.J. Gomez-Lechon, and J.V. Castell Cytokine signalling during myocardial infarction: sequential appearance of IL-1 beta and IL-6 Am. J. Physiol. 269 1995 R229 R235
41. M. Kobara, K. Noda, M. Kitamura, A. Okamoto, T. Shiraishi, H. Toba, H. Matsubara, and T. Nakata Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice Cardiovasc. Res. 87 2010 424 430
42. G.M. Froelich, P. Meyer, and S.K. White Myocardial reperfusion injury: looking beyond primary PCI Eur. Heart J. 34 2013 1714 1724